Registration into the STREAM platform clinical trials

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

This study looks at how people with acute myeloid leukaemia (AML) respond to treatment when their cancer comes back or doesn't respond well to initial therapy. It collects important real-world information to help improve care for patients across Europe.